Literature DB >> 33091459

Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration.

Sam A McConnell1, Adam J Brandner1, Brandon A Blank1, David N Kearns2, George F Koob1, Leandro F Vendruscolo1, Brendan J Tunstall3.   

Abstract

Opioid use disorder imposes great societal harm in the United States and in countries worldwide. Animal models that accurately capture motivational changes that occur in opioid dependence are critical to studying this disorder. The present study used a model of opioid vapor self-administration combined with a behavioral economics approach to determine whether rats would be more motivated to "work" to defend their baseline intake of fentanyl (i.e., more inelastic demand) following sufficiently frequent, intense, and chronic exposure to self-administered vaporized fentanyl. Male rats were allowed to respond for deliveries of 1.5-s of vaporized 10 mg/ml fentanyl solution. Following 15 sessions of short access (ShA; 1 h) vs. long access (LgA; 12 h) to self-administration, we conducted a between-sessions demand curve procedure, and observed significantly more inelastic demand for fentanyl (Essential Value; EV), and increased maximal response output (Omax) in LgA compared with ShA rats. In a subsequent phase, the unit-dose was doubled to 3 s of fentanyl vaporization. After seven ShA vs. LgA sessions, we assessed demand again and found that LgA rats, contrasted to ShA rats, demonstrated significantly higher baseline intake or "hedonic setpoint" (Q0), in addition to significantly increased EV and Omax. These results demonstrate that extended access to self-administration of a vaporized opioid causes changes in behavioral economic metrics consistent with development of an addiction-like state in rats. The combination of the vapor model with a translationally relevant behavioral economics framework opens new avenues to study dysregulated motivational processes in substance use disorders. Published by Elsevier Ltd.

Entities:  

Keywords:  Addiction; Behavioral economics; Motivation; Opioid dependence; Opioid use disorder

Mesh:

Substances:

Year:  2020        PMID: 33091459      PMCID: PMC7747488          DOI: 10.1016/j.neuropharm.2020.108355

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  34 in total

Review 1.  Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.

Authors:  Maciej Gasior; Mary Bond; Richard Malamut
Journal:  Postgrad Med       Date:  2015-12-18       Impact factor: 3.840

2.  Transition from moderate to excessive drug intake: change in hedonic set point.

Authors:  S H Ahmed; G F Koob
Journal:  Science       Date:  1998-10-09       Impact factor: 47.728

3.  Compulsive-Like Sufentanil Vapor Self-Administration in Rats.

Authors:  Janaina C M Vendruscolo; Brendan J Tunstall; Stephanie A Carmack; Brooke E Schmeichel; Emily G Lowery-Gionta; Maury Cole; Olivier George; Sophia A Vandewater; Michael A Taffe; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2017-08-16       Impact factor: 7.853

Review 4.  Abuse of fentanyl: An emerging problem to face.

Authors:  Katarzyna Kuczyńska; Piotr Grzonkowski; Łukasz Kacprzak; Jolanta B Zawilska
Journal:  Forensic Sci Int       Date:  2018-06-02       Impact factor: 2.395

5.  Demand for cocaine and food over time.

Authors:  Chesley J Christensen; Alan Silberberg; Steven R Hursh; Peter G Roma; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2008-07-20       Impact factor: 3.533

6.  A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.

Authors:  Choon-Gon Jang; Timothy Whitfield; Gery Schulteis; George F Koob; Sunmee Wee
Journal:  Psychopharmacology (Berl)       Date:  2012-09-25       Impact factor: 4.530

7.  Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats.

Authors:  Timothy G Freels; Lydia N Baxter-Potter; Janelle M Lugo; Nicholas C Glodosky; Hayden R Wright; Samantha L Baglot; Gavin N Petrie; Zhihao Yu; Brian H Clowers; Carrie Cuttler; Rita A Fuchs; Matthew N Hill; Ryan J McLaughlin
Journal:  J Neurosci       Date:  2020-01-17       Impact factor: 6.167

8.  Economic demand predicts addiction-like behavior and therapeutic efficacy of oxytocin in the rat.

Authors:  Brandon S Bentzley; Thomas C Jhou; Gary Aston-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

9.  The role of orexin-1 receptor signaling in demand for the opioid fentanyl.

Authors:  Jennifer E Fragale; Caroline B Pantazis; Morgan H James; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2019-05-21       Impact factor: 7.853

10.  Flavors Enhance Nicotine Vapor Self-administration in Male Mice.

Authors:  Skylar Y Cooper; Austin T Akers; Brandon J Henderson
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

View more
  8 in total

1.  Influence of Contingent and Noncontingent Drug Histories on the Development of High Levels of MDPV Self-Administration.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  J Pharmacol Exp Ther       Date:  2021-08-19       Impact factor: 4.030

2.  Corticosteroid sensitization drives opioid addiction.

Authors:  Stephanie A Carmack; Janaina C M Vendruscolo; M Adrienne McGinn; Jorge Miranda-Barrientos; Vez Repunte-Canonigo; Gabriel D Bosse; Daniele Mercatelli; Federico M Giorgi; Yu Fu; Anthony J Hinrich; Francine M Jodelka; Karen Ling; Robert O Messing; Randall T Peterson; Frank Rigo; Scott Edwards; Pietro P Sanna; Marisela Morales; Michelle L Hastings; George F Koob; Leandro F Vendruscolo
Journal:  Mol Psychiatry       Date:  2022-03-16       Impact factor: 13.437

3.  Reinforcing effects of fentanyl and sufentanil aerosol puffs in rats.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Psychopharmacology (Berl)       Date:  2022-04-15       Impact factor: 4.415

4.  Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience.

Authors:  Justin C Strickland; William W Stoops; Matthew L Banks; Cassandra D Gipson
Journal:  J Exp Anal Behav       Date:  2022-04-01       Impact factor: 2.215

Review 5.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

Review 6.  Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Authors:  Hanis Mohammad Hazani; Isa Naina Mohamed; Mustapha Muzaimi; Wael Mohamed; Mohamad Fairuz Yahaya; Seong Lin Teoh; Rashidi Mohamed Pakri Mohamed; Mohd Fadzli Mohamad Isa; Sundus Mansoor Abdulrahman; Ravi Ramadah; Mohammad Rahim Kamaluddin; Jaya Kumar
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

7.  Operant Vapor Self-administration in Mice.

Authors:  Renata C N Marchette; Brendan J Tunstall; Leandro F Vendruscolo; Khaled Moussawi
Journal:  Bio Protoc       Date:  2021-05-20

8.  A common limiter circuit for opioid choice and relapse identified in a rodent addiction model.

Authors:  Jasper A Heinsbroek; Giuseppe Giannotti; Mitchel R Mandel; Megan Josey; Gary Aston-Jones; Morgan H James; Jamie Peters
Journal:  Nat Commun       Date:  2021-08-09       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.